ARK ETF TR - GENOMIC REV ETF (ARKG)

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / GENOMIC REV ETF
Total 13F shares
770,723
Share change
+451,870
Total reported value
$19,841,482
Price per share
$25.75
Number of holders
38
Value change
+$11,638,696
Number of buys
32
Number of sells
4

Institutional Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) as of Q1 2018

As of 31 Mar 2018, ARK ETF TR - GENOMIC REV ETF (ARKG) was held by 38 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 770,723 shares. The largest 10 holders included MORGAN STANLEY, Edelman Financial Services, LLC, JANE STREET GROUP, LLC, UBS Group AG, LPL Financial LLC, FDx Advisors, Inc., Carroll Financial Associates, Inc., Strategic Wealth Advisors Group, LLC, HighTower Advisors, LLC, and ROYAL BANK OF CANADA. This page lists 39 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.